Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05488483 · ClinicalTrials.gov registry record
A Study of Tumor Imaging With Multispectral Optoacoustic Tomography
A clinical trial of Breast Cancer and Melanoma, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 12
- Enrollment target
- 4
- Study locations
NCT05488483 is a study of Breast Cancer and Melanoma that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 12 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT05488483, a study of Breast Cancer and Melanoma, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 12 participants
- Enrollment target
- 4
- Study locations
Study Summary
Participants in this study will have Multispectral Optoacoustic Tomography/MSOT imaging of both breasts immediately before their ultrasound-guided breast biopsy procedure begins. After the MSO imaging is completed, participation in the study will end.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Multispectral Optoacoustic Tomography Imaging
Study Locations (4)
New York
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only) - Commack
- Memorial Sloan - Kettering Cancer Center - New York
New Jersey
- Memorial Sloan Kettering Bergen (Consent only ) - Montvale
Other
- Helmholtz Institute (Data Analysis Only) - Munich
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-07-27 |
| Est. Completion | 2026-07-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05488483
The ClinicalTrials.gov registry entry for NCT05488483 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Multispectral Optoacoustic Tomography Imaging is the first listed.
NCT05488483 reports 4 study locations spanning 3 distinct geographic areas - top geographies include New York, New Jersey, Other.
Frequently Asked Questions
What is clinical trial NCT05488483 about?
NCT05488483 is a clinical study titled "A Study of Tumor Imaging With Multispectral Optoacoustic Tomography". Participants in this study will have Multispectral Optoacoustic Tomography/MSOT imaging of both breasts immediately before their ultrasound-guided breast biopsy procedure begins. After the MSO imaging is completed, participation in the study will end.
What is the current status of trial NCT05488483?
This trial is currently active not recruiting. The enrollment target is 12 participants. The study started on 2022-07-27. Estimated completion is 2026-07-27.
What conditions does trial NCT05488483 study?
This clinical trial studies the following conditions: Breast Cancer, Melanoma.
What interventions are being tested in trial NCT05488483?
The interventions under investigation include: Multispectral Optoacoustic Tomography Imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05488483?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05488483 being conducted?
This trial has 4 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.